SARS-CoV-2-IN-73
SARS-CoV-2-IN-73 (compound 4) is a SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) blocker[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-73.html
Solubility
10 mM in DMSO
Smiles
O=C(C=CN1[C@@H]2O[C@H](CNC(C3=C(O)C=C(O)C=C3O)=O)[C@@H](O)[C@]2(F)C)NC1=O
Molecular Formula
C17H18FN3O8
Molecular Weight
411.34
References & Citations
[1]Abdulwahed Alrehaily, et al. Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Sci Rep. 2023 Dec 27;13 (1) :23080.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal LEF1 Antibody (LEF1/341R) [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-08435JF549 100 µL
Rabbit Monoclonal LEF1 Antibody (LEF1/341R) [Janelia Fluor 549]
Ask
View Details MBS1024795-01 0.02 mg (E-Coli)
Recombinant Shigella flexneri Transcriptional regulatory protein uhpA (uhpA)
Ask
View Details